A detailed history of Alpha Mark Advisors, LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Alpha Mark Advisors, LLC holds 3,578 shares of LNTH stock, worth $319,479. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,578
Previous 545 556.51%
Holding current value
$319,479
Previous $44,000 793.18%
% of portfolio
0.14%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$77.7 - $123.62 $235,664 - $374,939
3,033 Added 556.51%
3,578 $393,000
Q1 2024

Apr 18, 2024

BUY
$51.07 - $68.26 $5,107 - $6,826
100 Added 22.47%
545 $34,000
Q1 2023

May 04, 2023

BUY
$47.76 - $82.86 $17,432 - $30,243
365 Added 456.25%
445 $37,000
Q4 2022

Feb 06, 2023

SELL
$48.76 - $77.67 $14,823 - $23,611
-304 Reduced 79.17%
80 $4,000
Q3 2022

Nov 14, 2022

BUY
$61.42 - $86.29 $23,585 - $33,135
384 New
384 $27,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.14B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Alpha Mark Advisors, LLC Portfolio

Follow Alpha Mark Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Mark Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Mark Advisors, LLC with notifications on news.